blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3138558

EP3138558 - LIPOSOME COMPOSITION AND PRODUCTION METHOD THEREFOR [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  12.04.2024
Database last updated on 04.11.2024
FormerThe patent has been granted
Status updated on  05.05.2023
FormerGrant of patent is intended
Status updated on  18.01.2023
FormerExamination is in progress
Status updated on  09.05.2020
FormerRequest for examination was made
Status updated on  03.02.2017
FormerThe international publication has been made
Status updated on  04.11.2016
Most recent event   Tooltip24.05.2024Lapse of the patent in a contracting state
New state(s): IT		published on 26.06.2024  [2024/26]
Applicant(s)For all designated states
FUJIFILM Corporation
26-30, Nishiazabu 2-chome
Minato-ku
Tokyo 106-8620 / JP
[2023/23]
Former [2021/14]For all designated states
FUJIFILM Corporation
26-30, Nishiazabu 2-chome, Minato-ku
Tokyo 106-8620 / JP
Former [2017/10]For all designated states
Fujifilm Corporation
26-30, Nishiazabu 2-chome Minato-ku
Tokyo 106-8620 / JP
Inventor(s)01 / ONO, Makoto
Ashigarakami-gun Kanagawa 258-8577 / JP
02 / ONO, Kohei
Ashigarakami-gun Kanagawa 258-8577 / JP
03 / MATSUMOTO, Takeshi
Ashigarakami-gun Kanagawa 258-8577 / JP
04 / MORI, Mikinaga
Ashigarakami-gun Kanagawa 258-8577 / JP
 [2023/23]
Former [2017/10]01 / ONO, Makoto
c/o FUJIFILM CORPORATION
577 Ushijima
Kaisei-machi
Ashigarakami-gun Kanagawa 258-8577 / JP
02 / ONO, Kohei
c/o FUJIFILM CORPORATION
577 Ushijima
Kaisei-machi
Ashigarakami-gun Kanagawa 258-8577 / JP
03 / MATSUMOTO, Takeshi
c/o FUJIFILM CORPORATION
577 Ushijima
Kaisei-machi
Ashigarakami-gun Kanagawa 258-8577 / JP
04 / MORI, Mikinaga
c/o FUJIFILM CORPORATION
577 Ushijima
Kaisei-machi
Ashigarakami-gun Kanagawa 258-8577 / JP
Representative(s)Hoffmann Eitle
Patent- und Rechtsanwälte PartmbB
Arabellastraße 30
81925 München / DE
[2017/10]
Application number, filing date15786541.130.04.2015
[2017/10]
WO2015JP62984
Priority number, dateJP2014009414130.04.2014         Original published format: JP 2014094141
[2017/10]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2015166987
Date:05.11.2015
Language:JA
[2015/44]
Type: A1 Application with search report 
No.:EP3138558
Date:08.03.2017
Language:EN
[2017/10]
Type: B1 Patent specification 
No.:EP3138558
Date:07.06.2023
Language:EN
[2023/23]
Search report(s)International search report - published on:JP05.11.2015
(Supplementary) European search report - dispatched on:EP02.01.2017
ClassificationIPC:A61K9/127, A61K31/7068, A61K47/24, A61K47/28, B82Y5/00
[2017/10]
CPC:
A61K31/7068 (EP,US); A61K9/127 (US); A61K47/24 (US);
A61K47/28 (US); A61K9/1271 (EP); A61K9/1278 (EP,US);
B82Y5/00 (US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/10]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
TitleGerman:LIPOSOMZUSAMMENSETZUNG UND HERSTELLUNGSVERFAHREN DAFÜR[2017/10]
English:LIPOSOME COMPOSITION AND PRODUCTION METHOD THEREFOR[2017/10]
French:COMPOSITION LIPOSOMALE ET PROCÉDÉ DE PRODUCTION ASSOCIÉ[2017/10]
Entry into regional phase28.10.2016Translation filed 
28.10.2016National basic fee paid 
28.10.2016Search fee paid 
28.10.2016Designation fee(s) paid 
28.10.2016Examination fee paid 
Examination procedure28.10.2016Examination requested  [2017/10]
28.10.2016Date on which the examining division has become responsible
17.07.2017Amendment by applicant (claims and/or description)
13.05.2020Despatch of a communication from the examining division (Time limit: M04)
17.09.2020Reply to a communication from the examining division
19.01.2023Communication of intention to grant the patent
27.04.2023Fee for grant paid
27.04.2023Fee for publishing/printing paid
27.04.2023Receipt of the translation of the claim(s)
Opposition(s)08.03.2024No opposition filed within time limit [2024/20]
Fees paidRenewal fee
10.04.2017Renewal fee patent year 03
11.04.2018Renewal fee patent year 04
15.04.2019Renewal fee patent year 05
31.03.2020Renewal fee patent year 06
15.04.2021Renewal fee patent year 07
21.03.2022Renewal fee patent year 08
16.03.2023Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT07.06.2023
CZ07.06.2023
DK07.06.2023
EE07.06.2023
ES07.06.2023
FI07.06.2023
HR07.06.2023
IT07.06.2023
LT07.06.2023
LV07.06.2023
NL07.06.2023
PL07.06.2023
RO07.06.2023
RS07.06.2023
SE07.06.2023
SI07.06.2023
SK07.06.2023
SM07.06.2023
NO07.09.2023
GR08.09.2023
IS07.10.2023
PT09.10.2023
[2024/26]
Former [2024/24]AT07.06.2023
CZ07.06.2023
DK07.06.2023
EE07.06.2023
ES07.06.2023
FI07.06.2023
HR07.06.2023
LT07.06.2023
LV07.06.2023
NL07.06.2023
PL07.06.2023
RO07.06.2023
RS07.06.2023
SE07.06.2023
SI07.06.2023
SK07.06.2023
SM07.06.2023
NO07.09.2023
GR08.09.2023
IS07.10.2023
PT09.10.2023
Former [2024/22]AT07.06.2023
CZ07.06.2023
DK07.06.2023
EE07.06.2023
ES07.06.2023
FI07.06.2023
HR07.06.2023
LT07.06.2023
LV07.06.2023
NL07.06.2023
PL07.06.2023
RO07.06.2023
RS07.06.2023
SE07.06.2023
SK07.06.2023
SM07.06.2023
NO07.09.2023
GR08.09.2023
IS07.10.2023
PT09.10.2023
Former [2024/10]AT07.06.2023
CZ07.06.2023
EE07.06.2023
ES07.06.2023
FI07.06.2023
HR07.06.2023
LT07.06.2023
LV07.06.2023
NL07.06.2023
PL07.06.2023
RO07.06.2023
RS07.06.2023
SE07.06.2023
SK07.06.2023
SM07.06.2023
NO07.09.2023
GR08.09.2023
IS07.10.2023
PT09.10.2023
Former [2024/09]AT07.06.2023
CZ07.06.2023
ES07.06.2023
FI07.06.2023
HR07.06.2023
LT07.06.2023
LV07.06.2023
NL07.06.2023
RS07.06.2023
SE07.06.2023
SK07.06.2023
SM07.06.2023
NO07.09.2023
GR08.09.2023
IS07.10.2023
Former [2024/08]ES07.06.2023
FI07.06.2023
HR07.06.2023
LT07.06.2023
LV07.06.2023
NL07.06.2023
RS07.06.2023
SE07.06.2023
SK07.06.2023
SM07.06.2023
NO07.09.2023
GR08.09.2023
Former [2024/03]ES07.06.2023
FI07.06.2023
HR07.06.2023
LT07.06.2023
LV07.06.2023
NL07.06.2023
RS07.06.2023
SE07.06.2023
NO07.09.2023
GR08.09.2023
Former [2024/01]ES07.06.2023
HR07.06.2023
LT07.06.2023
LV07.06.2023
NL07.06.2023
RS07.06.2023
SE07.06.2023
NO07.09.2023
GR08.09.2023
Former [2023/52]ES07.06.2023
HR07.06.2023
NL07.06.2023
RS07.06.2023
SE07.06.2023
NO07.09.2023
GR08.09.2023
Former [2023/51]ES07.06.2023
HR07.06.2023
RS07.06.2023
SE07.06.2023
NO07.09.2023
GR08.09.2023
Former [2023/50]ES07.06.2023
SE07.06.2023
NO07.09.2023
GR08.09.2023
Former [2023/48]ES07.06.2023
SE07.06.2023
NO07.09.2023
Former [2023/46]ES07.06.2023
Documents cited:Search[X]WO2007005754  (ALZA CORP [US], et al) [X] 1-8* pages 15-16 *
International search[XY]JPH021404  (TAKEDA CHEMICAL INDUSTRIES LTD) [X] 1, 2, 5 * , claims; examples & US 5094854 A & EP 0331504 A1 * [Y] 2, 4, 6-8;
 [XY]JPH069374  (BANYU PHARMA CO LTD [JP]) [X] 1, 3, 5 * , claims; examples & EP 0565361 A1 * [Y] 4;
 [XY]JP2007536247  (Hermes Biosciences, Inc.) [X] 1, 3, 5 * , claims; paragraphs [0074] to [0077], [0160], [0262] & US 2007/0110798 A1 & WO 2005/107712 A1 & EP 1746976 A1 & KR 10-2007-0036055 A & CN 1980637 A * [Y] 2, 4, 6-8;
 [XY]JP2013508315  (Bio-Bedst ApS) [X] 1, 3, 5 * , claims; paragraph [0070]; examples & US 2012/0219618 A1 & WO 2011/047689 A2 & EP 2490671 A1 & CN 102639114 A * [Y] 4;
 [XY]JP2013526563  (MEDIGENE AG) [X] 1, 3, 5 * , claims; paragraphs [0058], [0114]; examples & US 2013/0259922 A1 & WO 2011/144745 A2 & EP 2394640 A1 & CN 103002876 A & KR 10-2013-0085368 A * [Y] 2, 4, 6-8;
 [Y]JP2013126953  (TERUMO CORP) [Y] 4* , paragraph [0032] & WO 2011/125848 A1 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.